Understanding how glypican Dlp regulates Wnt signaling in cells

Mechanisms of Wg/Wnt regulation by glypican Dlp

NIH-funded research University of Massachusetts Lowell · NIH-11002347

This study looks at how a protein called glypican Dlp helps control a signaling system that affects how cells grow and move, using fruit flies as a model, to better understand how changes in this process might relate to cancer.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionUniversity of Massachusetts Lowell NIH-funded
Lab location1 site (Lowell, United States)
Project IDNIH-11002347 on NIH RePORTER

What this research studies

This research investigates the role of glypican Dlp in regulating Wnt signaling, a crucial pathway that influences cell behaviors such as growth and movement. By studying the Drosophila germarium, a model for understanding these processes, the research aims to uncover how Dlp affects the availability of Wnt ligands, which are essential for proper cell communication and tissue development. The approach involves examining the molecular mechanisms of Dlp's interaction with Wnt and its impact on signaling ranges, which could provide insights into how these processes are altered in cancers.

Who could benefit from this research

Good fit: Ideal candidates for this research are individuals with epithelial cancers where Wnt signaling is known to be deregulated.

Not a fit: Patients with non-epithelial cancers or those not affected by Wnt signaling pathways may not benefit from this research.

Why it matters

Potential benefit: If successful, this research could lead to new strategies for targeting Wnt signaling in cancer treatment.

How similar studies have performed: Previous research has shown that targeting Wnt signaling can be effective in cancer therapies, indicating potential for success in this area.

Where this research is happening

Lowell, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions Cancer cell line
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.